Research article summary (published 30 Mar 2008):

Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.

Full Abstract

In recent years the medication options for the treatment of ADHD in children and young people have increased. The National Institute for Health and Clinical Excellence (NICE) produced updated guidelines in 2006. This paper aims to interpret these guidelines by reviewing the medication options in light of relevant research and clinical practice. The properties of methylphenidate, dexamfetamine and atomoxetine are discussed.

Author information

Author/s: Harpin, V A (VA);

Affiliation: Ryegate Childrens Centre, Sheffield Children's NHS Foundation Trust, Tapton Crescent Road, Sheffield S10 5DD, UK. val.harpin(-atsign-)sch.nhs.uk

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal: Archives of disease in childhood. Education and practice edition (Arch Dis Child Educ Pract Ed), published in England. (Language: eng)

Reference: 2008-Apr; vol 93 (issue 2) : pp 58-65

Dates: Created 2008/03/21; Completed 2008/05/06;

PMID: 18356307, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: 18 Feb 2009 00:00:00)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Adolescent Adrenergic Uptake Inhibitors - adverse effects; therapeutic use Attention Deficit Disorder with Hyperactivity - drug therapy Central Nervous System Stimulants - adverse effects; therapeutic use Child Child, Preschool

Child, Preschool Dextroamphetamine - adverse effects; therapeutic use Humans Methylphenidate - adverse effects; therapeutic use Practice Guidelines as Topic Propylamines - adverse effects; therapeutic use

Associated Chemicals: Adrenergic Uptake Inhibitors (0) ; Central Nervous System Stimulants (0) ; Propylamines (0) ; Methylphenidate (113-45-1) ; Dextroamphetamine (51-64-9) ; atomoxetine (83015-26-3)

Related articles

These are the highest related articles currently in the database:

• Improving decision making in the treatment of ADHD. 30 May 2008
• Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. 27 Feb 2007
• An update on attention deficit disorder. 29 Apr 2004
• Treatment of attention-deficit-hyperactivity disorder. 9 Mar 1999
• Has NICE got it right? An international perspective considering the case of Technology Appraisal No. 98 by the National Institute for Health and Clinical Excellence (NICE). 12 Feb 2008
• Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. 28 May 2006
• Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence. 30 Dec 2003
• Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder. 30 Dec 1990
• Treatment of adult ADHD and comorbid disorders. 29 Sep 2006
• Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study. 30 Aug 2005

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.